Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical fusidic acid versus mometasone after fractional CO2 laser for acne scars
IRCT20250630066301N1Phase 4Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind trial of fusidic acid and mometasone in acne scar (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Dermatologist-scored lesion improvement, Patient satisfaction with lesion improvement and 3 more. Started Jun 2025; status: completed.
02
Drugs
fusidic acidmometasone
03
Conditions
acne scar
Beyond the preview
Go deeper on IRCT20250630066301N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250630066301N1.